Business Context and Reporting Period
Company: OrthoPediatrics Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: August 4, 2022
Reporting Period: This filing reports on events occurring on August 4, 2022, specifically regarding upcoming investor presentations.
Key Financial Metrics
This Form 8-K does not contain financial statements, revenue figures, profit data, cash flow, margins, debt levels, or liquidity metrics. The filing serves solely to disclose the use of an investor presentation for upcoming meetings.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing indicates that executive officers intend to use the material in Exhibit 99.1 (Investor Presentation dated August 2022) for upcoming presentations to investors and analysts.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms upcoming presentations by executive officers to representatives of investors and analysts.
Regulatory Disclosure: The information provided, including the referenced Exhibit 99.1, is furnished pursuant to Item 7.01 of Regulation FD and is not deemed "filed" for purposes of Section 18 of the Exchange Act, nor is it incorporated by reference into other filings unless expressly stated.
Risks and Contingencies: No specific risks or contingencies are detailed in this filing text.
Investor Verification Checklist
- Review Exhibit 99.1 (OrthoPediatrics Corp. Investor Presentation dated August 2022) for actual financial data and strategic outlook, as this 8-K only references the document.
- Verify the content of the investor presentation to understand the specific guidance or updates intended for the upcoming analyst meetings.
- Confirm that the presentation materials are not considered "filed" for legal liability purposes under Section 18 of the Exchange Act, as noted in the filing.